Senomyx (Senomyx) Cash And Cash Equivalents : $4.49 Mil (As of Jun. 2018)

View and export this data going back to 2004. Start your Free Trial

What is Senomyx Cash And Cash Equivalents?

Senomyx's quarterly cash and cash equivalents increased from Dec. 2017 ($6.23 Mil) to Mar. 2018 ($10.34 Mil) but then stayed the same from Mar. 2018 ($10.34 Mil) to Jun. 2018 ($4.49 Mil).

Senomyx's annual cash and cash equivalents declined from Dec. 2015 ($4.82 Mil) to Dec. 2016 ($3.59 Mil) but then increased from Dec. 2016 ($3.59 Mil) to Dec. 2017 ($6.23 Mil).

Senomyx Cash And Cash Equivalents Historical Data

The historical data trend for Senomyx's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Senomyx Cash And Cash Equivalents Chart

Senomyx Annual Data

Trend

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Cash And Cash Equivalents

Get a 7-Day Free Trial

11.20

3.96

4.82

3.59

6.23

Senomyx Quarterly Data
	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18
Cash And Cash Equivalents	Get a 7-Day Free Trial															5.52	3.92	6.23	10.34	4.49

Senomyx Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Senomyx (NAS:SNMX) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Senomyx Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Senomyx's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Senomyx (Senomyx) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Senomyx Inc (NAS:SNMX) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.senomyx.com

Senomyx Inc manufactures and sells a variety of favors for the packaged food, beverage, and ingredient supply industries. The firm's product portfolio has three primary categories: sweetmyx, savorymyx, and bittermyx. Sweetmyx ingredients are used to increase a product's sweet taste while reducing sugar usage. Savorymyx ingredients are used to increase a product's savory flavors as well as reduce MSG, nucleotides, and sodium in food and beverage products. Bittermyx ingredients are used to reduce a product's bitter taste.

Executives

Christopher J Twomey	director	4767 NEXUS CENTRE DRIVE, SAN DIEGO CA 92121
John Poyhonen	director, officer: President & CEO	11088 N TORREY PINES RD, C/O SENOMYX INC, LA JOLLA CA 92037
Stephen A Block	director	INTERNATIONAL FLAVORS & FRAGRANCES INC., 521 WEST 57TH ST, NEW YORK NY 10019
Mary Ann Gray	director	201 W 70TH ST, SUITE 23K, NEW YORK NY 10023
Richard R Mashaal	10 percent owner	C/O RIMA SENVEST MANAGEMENT, L.L.C., 540 MADISON AVENUE, 32ND FLOOR, NEW YORK NY 10022
Senvest Management, Llc	10 percent owner	540 MADISON AVENUE, 32ND FLOOR, NEW YORK NY 10022
Michael E Herman	director	CERNER CORP 2800 ROCKCREEK PARKWAY KANSAS CITY MO 64117-2551
David B Berger	officer: Sr. V.P. Gen. Counsel & Sec.	11045 ROSELLE STREET, SAN DIEGO CA 92121
Dennis F Obrien	director	SENOMYX INC, 11099 NORTH TORREY PINES ROAD, LA JOLLA CA 92037
Harry J Leonhardt	officer: SVP, Gen.Counsel & Corp. Sec.	C/O HALOZYME THERAPEUTICS, INC., 11388 SORRENTO VALLEY BLVD., SAN DIEGO CA 92121
Mark Leschly	director	RHO CAPITAL PARTNERS, INC., 152 W 57TH ST 23RD FL, NEW YORK NY 10019
David Schnell	director	525 UNIVERSITY AVE, SUITE 1350, PALO ALTO CA 94301
Timothy J Wollaeger	director
Beeley Nigel R A	officer: VP Discovery	ARENA PHARMACEUTICALS INC 6166 NANCY RIDER DRIVER SAN DIEGO CA 92121
Rho Management Trust I	10 percent owner	C/O RHO CAPITAL PARTNERS, INC., 152 W. 57TH STREET, 23RD FLOOR, NEW YORK NY 10019